Mainland Brokerages Suspend New Cross-Border Equity TRS, Private Fund Channels for HK/US Stock Allocation Continue to Tighten
Taylor Wilson
On the evening of June 23, multiple brokers notified private fund managers that new positions in equity cross-border TRS are suspended effective immediately; existing positions may expire or be closed normally. This means the last major channel for mainland private funds to access Hong Kong and US equities via TRS is being squeezed further.
What just happened?
On June 23, brokers acting on regulatory window guidance told private funds: no new opening positions in equity cross-border TRS, effective June 24.
Existing positions can expire or be unwound normally — no forced liquidation.
The industry is still waiting for detailed rules: will all new positions be frozen, or can managers reallocate within existing quotas?
What is cross-border TRS, and why do private funds use it?
A cross-border TRS (total return swap) is an OTC derivative. A private fund signs a swap agreement with a broker and receives the return exposure of a foreign stock — without sending capital offshore or holding the asset directly.
This means → it is essentially a channel where the investor stays onshore, the money stays onshore, but the gains and losses track an overseas stock.
The broker (proprietary desk or offshore subsidiary) holds the underlying asset first, then transfers return and risk to the onshore client via the TRS contract. Clients typically post 100% margin and must qualify as professional investors.
Did this come out of nowhere?
No. Since 2024, cross-border TRS has been subject to a "no net increase" quota constraint. This latest move tightens the same framework by explicitly banning new opening positions in the equity sub-category.
The backdrop: strong global tech stocks in 2025, plus a May crackdown by eight government agencies on illegal cross-border securities activity, drove rapid growth in TRS-channeled offshore tech allocations by private funds.
This reflects the regulator's core logic: not rejecting overseas allocation itself, but preventing equity TRS from scaling too fast and becoming a de facto channel for personal capital to leave the country.
How much does this hurt broker revenue?
The impact is marginal. Industry estimates put the outstanding equity cross-border TRS book at roughly RMB 200–300 billion. At an annualized fee rate of about 1.5%, that implies annual net income of roughly RMB 3–4.5 billion.
In plain terms = that is 0.5%–0.8% of listed brokers' total revenue, or about 1.3%–2% for the top five — not zero, but far from a material blow.
What are the knock-on effects for semiconductor stocks?
Chinese private funds have become one of the more sophisticated and forward-looking research forces in the global semiconductor supply chain, with early positions in names like LITE (photonics) and SNDK (memory), spanning MLCC, power semis, analog chips, specialty materials, equipment, and components across Korea, Taiwan, and Japan.
If new TRS positions remain restricted, some smaller-cap overseas semiconductor companies may lose an important source of marginal buying and price discovery.
This means → the adjustment is broadly negative for Korean, Taiwanese, and Japanese semiconductor stocks, but potentially positive for Hong Kong-listed semiconductor names — some capital may redirect toward markets with fewer outbound constraints.
Are futures and bond TRS affected too?
This round of regulation explicitly targets equity cross-border TRS. Futures TRS, LGFV-bond TRS, and certain FICC and northbound-related businesses are not included for now.
In practice, however, many brokers manage equity, futures, and bond cross-border TRS under one shared credit or risk-quota pool.
This means → once the equity bucket is frozen, quota reallocation and rollover arrangements will still create chain effects on firms' broader cross-border positioning — products not formally tightened may see their real operating room shrink anyway.
Content is for reference only, not financial advice.